IIFLCAPS Q2 FY27 Earnings Call: Fairfax 51% Deal Closing November 2026, Operational PBT Up 40% QoQ

IIFLCAPS held its Q2 FY27 earnings call on October 28, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Strong Sequential Momentum, MTM Drag from BSE Stake

• Consolidated operational revenue of Rs.722 Cr — up 14% QoQ and 22% YoY in Q2 FY 2026-2027; operational PBT (before mark-to-market) at Rs.206 Cr, up ~40% QoQ and 25% YoY.
• MTM loss of Rs.32 Cr — driven by adverse BSE share price movement (vs MTM gains in Q1 FY27); the company continues to hold 5.95 lakh BSE shares as a legacy investment, the main driver of MTM.
• H1 FY27 operational PBT up 8% to Rs.355 Cr — before MTM, versus H1 FY 2025-2026.
• Average daily turnover of Rs.3,05,073 Cr — down ~3% QoQ (vs Rs.3,15,780 Cr in Q1 FY27) but up 16% YoY (vs Rs.2,63,568 Cr in Q2 FY26); F&O at Rs.3,01,785 Cr and cash at Rs.3,288 Cr. Management said it performed reasonably well against the overall decline in market volumes.
• India GDP grew 7.8% in Q1 FY27 — supported by manufacturing and services; management flagged geopolitical tensions, elevated oil prices, high interest rates, inflation/crude/currency pressures, and foreign outflows as monitorables, while stating India's medium-term fundamentals remain strong.

Broad-Based Growth; Insurance and FPD Lag

• Retail equities income of Rs.316 Cr — up 6% QoQ and 17% YoY in Q2 FY 2026-2027; H1 FY27 retail equity income up 15% to Rs.613 Cr.
• Institutional & banking income of Rs.245 Cr — up 18% QoQ (vs Rs.207 Cr in Q1 FY27) and 31% YoY, with traction in both broking and banking; H1 FY27 institutional broking income up 16% to Rs.451 Cr (vs Rs.390 Cr).
• Institutional broking plus investment banking revenue of roughly Rs.450 Cr — estimated split of Rs.250 Cr institutional broking and Rs.200 Cr investment banking in Q2 FY 2026-2027.
• FPD/distribution income of Rs.159 Cr — up 27% QoQ and 23% YoY; H1 FY27 FPD income broadly flat at Rs.285 Cr vs Rs.275 Cr (Q1 FY26 included exceptional upfront transactional income).
• ARR assets in FPD/distribution grew 5% sequentially — management expects ARR AUM growth to be the key income driver going forward; Q2 ARR income growth was driven by AIF, PMS, and mutual fund.
• Insurance underperformed in Q2 FY 2026-2027 — management expects an uptick in insurance income over Q3 and Q4 FY 2026-2027.
• PMS AUM declined in Q2 FY 2026-2027 — due to outflows in the NDPMS, which management hopes to recover in the coming days.

Employee Cost Run-Rate Guided; Wealth Break-Even Ahead

• Employee costs up 8% QoQ and 26% YoY to Rs.194 Cr — driven by bonus provisions, ~5% headcount growth, higher variable pay, and high wage inflation in FY 2026-2027; additions were in the AMC business within wealth, not wealth RMs.
• Quarterly employee cost run-rate of roughly Rs.192-194 Cr guided — for the remainder of FY 2026-2027.
• Finance costs up 25% QoQ to Rs.75 Cr and 40% YoY — on higher borrowings; depreciation up 6% QoQ to Rs.18 Cr and 16% YoY (branches and technology); admin expenses up 9% QoQ to Rs.96 Cr, mainly technology investments; fees & commissions down 4% QoQ to Rs.134 Cr but up 13% YoY.
• SPD (wealth distribution) fee economics disclosed — in-house equity products earn roughly 2-2.5% fees; third-party equity products earn about a 50% cut relative to in-house rates (analyst Krish Agarwal summarized as ~2% own vs ~1% third-party). Management characterized these as rough, directional numbers.
• FPD (wealth) business expected to break even in 6-18 months — i.e., during FY 2027-2028; the business comprises clients migrated from broking into HNI broking plus newly started business, and is currently loss-making (H1 FY 2026-2027 loss figure not available on call; to be shared separately).
• In-house manufacturing book at approximately Rs.4,500 Cr — as of Q2 FY 2026-2027; management is investing in this and expects it to take longer to break even (period unspecified).

51% Acquisition Approved; Closing Expected November 2026

• All requisite regulatory and shareholder approvals received — FIH Fairfax Mauritius Investments for the proposed acquisition of 51% of the company via preferential allotment, open offer, and other arrangements with the promoters; pref allotment and open offer are under implementation, with closing expected in November 2026.
• Open offer structure clarified — MD R. Venkataraman explained the acquirer will make an open offer, and if shares tendered do not take the acquirer to 51% ownership, the promoters will then sell shares to make the acquirer 51%.
• Promoter group will not tender shares in the open offer — Venkataraman explicitly noted this stance is stated on behalf of the promoters only, not for all shareholders; promoter shares will be offered only as and when the open offer concludes, and only if the acquirer falls short of the 51% threshold through tendering.
• Bulk of the Fairfax fund infusion to go toward margin funding — with repayment of borrowings as the other broad use of funds; exact details are in the open offer document, which management offered to share via email.
• Bank subsumption framed as long-term outcome — asked by Abhijit Sakare (Kotak Securities) whether the end goal is a roll-up into the banking license, Venkataraman said the Fairfax press release states that "ultimately the interests of both GoDigit and IIFL Capital will get subsumed into the bank," possibly as a subsidiary; management deferred detailed commentary, saying the question is better answered by "Capex people" themselves (as transcribed).

NBFC Subsidiary Planned; Insurance Stance Exploratory

• Wholly owned NBFC subsidiary proposed — to expand financial services offerings and develop lending and credit solutions for the HNI segment, subject to regulatory approvals from RBI.
• Insurance distribution now a "marginal" business — with some amount of dip in performance over the last 2 quarters (through Q2 FY 2026-2027); management will focus on the insurance business over the next 2 quarters (Q3-Q4 FY 2026-2027), ahead of new regulations kicking in (no specific regulator named).
• Long-term focus framed as an open question — between capital markets distribution and insurance distribution, rather than a committed shift toward capital markets.
• Open to all discussions on the insurance business — responding to an analyst's question on a potential sale, management said it is "open to all discussions to enhance shareholder value" and will explore (an exploratory stance, not a committed divestment decision).
• RBI regulations effective from Q2 FY 2026-2027 — management said the broking business saw only a marginal impact, essentially no impact.

Vasudev Jagannath to Become MD from January 2027

• Board approved Vasudev Jagannath as additional director and whole-time director — for three years, subject to requisite regulatory approvals; he will be designated Managing Director effective January 1, 2027, while R. Venkataraman continues on the board.
• Jagannath brings ~3 decades in capital markets — an IIM Calcutta MBA with 2 decades at IIFL Capital and prior roles at CLSA (New York desk; head of sales).
• Management remains available offline — R. Venkataraman shared his direct email (venkat@IFLCAPITAL.com) and confirmed he and Raunak remain available for further analyst questions; no new financial figures or guidance were provided in the closing segment.